Zuora, Inc.
Zuora Shareholders Should Contact Julie & Holleman Regarding Investigation of Buyout
Zuora Shareholders Should Contact Julie & Holleman Regarding Investigation of Buyout
Thoughtworks Shareholders Should Contact Julie & Holleman Regarding Investigation of Buyout by Apax
Bally’s Shareholders Should Contact Julie & Holleman Regarding Investigation of Buyout by Standard General
PowerSchool Shareholders Should Contact Julie & Holleman Regarding Investigation of Buyout by Bain Capital
Avangrid Shareholders Should Contact Julie & Holleman Regarding Investigation of Buyout by Iberdrola
Squarespace Shareholders Should Contact Julie & Holleman Regarding Investigation of Buyout by Permira
VIZIO Shareholders Should Contact Julie & Holleman Regarding Investigation of Merger With Walmart
Transphorm, Inc. (Nasdaq: TGAN) Julie & Holleman LLP is investigating the proposed sale of Transphorm, Inc. (Nasdaq: TGAN) to Renesas Electronics Corporation. Julie & Holleman believes the $5.10 per share deal price may be unfair, and the firm has identified… Read More »Transphorm, Inc.
HireRight Holdings Corp. (NYSE: HRT) Julie & Holleman LLP, a law firm dedicated to representing shareholders, is investigating potential breaches of fiduciary duty related to the proposed acquisition of HireRight Holdings Corporation (NYSE: HRT) by its controlling shareholders, private equity… Read More »HireRight Holdings Corp.
Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) NEW YORK, December 6, 2023—Julie & Holleman LLP, a nationally recognized shareholder rights law firm, is investigating the proposed $45 per share sale of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) to AbbVie Inc. The firm… Read More »Cerevel Therapeutics Holdings, Inc.